Given the complete suppression of gliomagenesis upon loss of Id1, Id2, and Id3 in a murine model76 and the ability of AGX51 to antagonize all members of the family, it is likely that sufficient exposure of these brain tumors to AGX51 will provide some therapeutic benefit. The gene discussed is ID2; the disease is brain neoplasm.